Pharmacokinetics of antisense oligonucleotide drugs
This review covers the pharmacokinetic characteristics of the various antisense oligonucleotide drugs. A comparison of the pharmacokinetics of drugs first and second generation. As well as the influence on the pharmacokinetics of the chemical modification of the molecule.
Saved in:
Main Authors: | M. R. Khaitov, V. V. Smirnov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC “Publisher OKI”
2013-04-01
|
Series: | Фармакокинетика и Фармакодинамика |
Subjects: | |
Online Access: | https://www.pharmacokinetica.ru/jour/article/view/124 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antisense oligonucleotides for the arterial hypertension mechanisms study and therapy
by: L. O. Klimov, et al.
Published: (2018-04-01) -
ANTISENSE OLIGONUCLEOTIDES AND THERAPEUTICAL MONOCLONAL ANTIBODIES AS A BASEMENT FOR NOVEL BIOLOGICAL LIPIDLOWERING DRUGS
by: O. I. Afanasieva, et al.
Published: (2018-09-01) -
LIPID METABOLISM CORRECTION BY ANTISENSE TECHNOLOGY
by: O. I. Afanasieva, et al.
Published: (2015-09-01) -
A Convenient Fluorogenic Detection Strategy for Phosphorothioate Modification of DNA Through Photocatalytic Oligonucleotide-Templated Reaction
by: Nannan Jing, et al.
Published: (2025-05-01) -
Changes induced in mouse lipid metabolism by simultaneous impact of antisense oligonucleotide derivatives to <i>apoB</i>, <i>PCSK9</i>, and <i>apoCIII</i> mRNAs
by: S. I. Oshevski, et al.
Published: (2020-01-01)